opentrade on 
↗
↗event5 outcomes
Will the FDA approve intismeran autogene (V940/mRNA-4157)?
·Science and Technology·ends Jul 8, 2028vol cum
$693
vol 24h
$25
outcomes
5
ends
Jul 8, 2028
outcomesclick to inspect →
marketselected outcome
Before Jan 1, 2028
rank #1
United States
84¢
· 0.0pp
24h change
vol cum
$312
vol 24h
$25
spread
0.04
ends
Jan 8, 2028
If the FDA approves intismeran autogene (V940/mRNA-4157) with pembrolizumab (KEYTRUDA) for adjuvant treatment of completely resected stage IIB-IV melanoma for marketing before Jan 1, 2028, then the market resolves to Yes.
timeline
opened · Aug 19, 2026opencloses · Jan 8, 2028
Before Jan 1, 2028 · prices over time
−24h
now
volume · by outcomehover a column to inspect
no volume history
similar markets
suggested by pdatakalshiWill the FDA approve retatrutide?
Before Jul 1, 202747¢▲ 3.0ppBefore Jan 1, 202714¢▲ 1.0ppBefore Jan 1, 202999¢
+2 others
$10 24h · 5 markets
polymarketFDA approves Retatrutide this year?
yes3¢▼ 1.7pp
$103 24h · 1 market
Will AOH1996 be FDA approved before 2040?
yes40¢
M0 24h · 1 market
kalshiWill the FDA approve VERVE-102?
Before 203587¢Before 203481¢· 0.0ppBefore 203276¢
+3 others
$0 24h · 6 markets
polymarketFDA approves skin cancer vaccine by...?
December 31, 202765¢▲ 4.0ppJune 30, 202728¢· 0.0ppSeptember 30, 202741¢· 0.0pp
$4.5k 24h · 3 markets
The FDA will approve an AI developed cure before the end of the decade (<2030) for a previously incurable major illness.
yes26¢
M0 24h · 1 market